← FDA Drug Approvals (Drugs@FDA)

LAMIVUDINE; ZIDOVUDINE; EFAVIRENZ

NDA · New Drug Application · Sponsor: MYLAN LABS LTD · Approved 2014-09-04

Drug application

FDA Application #

NDA206040

Application type

New Drug Application

Brand name

LAMIVUDINE; ZIDOVUDINE; EFAVIRENZ

Generic name

Lamivudine

Active ingredients

LAMIVUDINE; ZIDOVUDINE; EFAVIRENZ

Dosage form

TABLET

Route

ORAL

Marketing status

None (Tentative Approval)

Sponsor

MYLAN LABS LTD

First approval

2014-09-04

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown